Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001241172 | SCV001414171 | pathogenic | Neurofibromatosis, type 1 | 2021-06-25 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 966483). This premature translational stop signal has been observed in individual(s) with pilocytic astrocytoma (PMID: 2948975). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr2377*) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). |
Baylor Genetics | RCV003469457 | SCV004190771 | pathogenic | Juvenile myelomonocytic leukemia | 2022-12-27 | criteria provided, single submitter | clinical testing | |
Beijing Key Laboratory for Genetic Research of Skeletal Deformity, |
RCV001241172 | SCV001482400 | pathogenic | Neurofibromatosis, type 1 | 2019-05-31 | no assertion criteria provided | research |